| ISIN | CH0039299513 |
|---|---|
| Valor Number | 3929951 |
| Bloomberg Global ID | BBG000KL16D1 |
| Fund Name | Swisscanto (CH) Equity Fund Responsible Switzerland High Quality NT CHF |
| Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
| Fund Provider | Swisscanto Fondsleitung AG |
| Representative in Switzerland | |
| Distributor(s) | Schweizerische Kantonalbanken |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | Special conditions apply to the issue of units |
| Redemption Condition | Special conditions apply to the redemption of units |
| Investment Strategy *** | The fund aims to exceed the performance of its benchmark on 3 years rolling periods, by investing in bonds of debtors that are considered to run their businesses with sustainability. |
| Peculiarities |
| Current Price * | 5,062.56 CHF | 08.01.2026 |
|---|---|---|
| Previous Price * | 5,057.33 CHF | 07.01.2026 |
| 52 Week High * | 5,062.56 CHF | 08.01.2026 |
| 52 Week Low * | 4,134.97 CHF | 09.04.2025 |
| NAV * | 5,062.56 CHF | 08.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 826,395,874 | |
| Unit/Share Assets *** | 650,946,297 | |
| Trading Information SIX | ||
| YTD Performance | +1.35% |
31.12.2025 - 08.01.2026
31.12.2025 08.01.2026 |
|---|---|---|
| 1 month | +3.07% |
08.12.2025 - 08.01.2026
08.12.2025 08.01.2026 |
| 3 months | +3.75% |
08.10.2025 - 08.01.2026
08.10.2025 08.01.2026 |
| 6 months | +6.87% |
08.07.2025 - 08.01.2026
08.07.2025 08.01.2026 |
| 1 year | +11.78% |
08.01.2025 - 08.01.2026
08.01.2025 08.01.2026 |
| 2 years | +21.80% |
08.01.2024 - 08.01.2026
08.01.2024 08.01.2026 |
| 3 years | +21.00% |
09.01.2023 - 08.01.2026
09.01.2023 08.01.2026 |
| 5 years | +25.92% |
08.01.2021 - 08.01.2026
08.01.2021 08.01.2026 |
| Equity Participation Rate in % | 99.22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 12.11% | |
|---|---|---|
| Novartis AG Registered Shares | 10.15% | |
| Nestle SA | 10.02% | |
| ABB Ltd | 6.60% | |
| UBS Group AG Registered Shares | 4.91% | |
| Compagnie Financiere Richemont SA Class A | 4.91% | |
| Zurich Insurance Group AG | 4.09% | |
| Lonza Group Ltd | 3.61% | |
| Swiss Re AG | 3.42% | |
| Givaudan SA | 2.78% | |
| Last data update | 30.11.2025 | |
| TER | 0.00% |
|---|---|
| TER date | 31.10.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | |
| Ongoing Charges *** | 0.00% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |